We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTK
76
DELISTED
DermTech, Inc. Common Stock
DMTK
$4.81M 0.25%
402,718
-68,425
-15% -$793K
HAE icon
77
Haemonetics
HAE
$4.16B
$4.8M 0.25%
+55,000
New +$4.81M
LHCG
78
DELISTED
LHC Group LLC
LHCG
$4.78M 0.25%
22,497
-43,862
-66% -$8.66M
TELA icon
79
TELA Bio
TELA
$32.3M
$4.77M 0.25%
+288,605
New +$4.05M
NARI
80
DELISTED
Inari Medical, Inc. Common Stock
NARI
$4.66M 0.24%
67,500
+10,375
+18% +$667K
AAL icon
81
CALL
American Airlines Group
AAL
$9.88B
$4.59M 0.24%
+373,800
New +$4.69M
BLFS icon
82
BioLife Solutions
BLFS
$1.71B
$4.49M 0.23%
+155,000
New +$3.35M
NSTG
83
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$4.47M 0.23%
100,000
-2,000
-2% -$77.7K
TRIL
84
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.47M 0.23%
314,487
+215,700
+218% +$2.15M
NVRO
85
DELISTED
NEVRO CORP.
NVRO
$4.43M 0.23%
+31,838
New +$4.25M
BNR
86
Burning Rock Biotech
BNR
$105M
$4.43M 0.23%
+17,664
New +$4.19M
TWST icon
87
Twist Bioscience
TWST
$7.85B
$4.37M 0.23%
57,581
-50,600
-47% -$3.15M
OPCH icon
88
Option Care Health
OPCH
$3.57B
$4.34M 0.22%
+325,000
New +$3.95M
APYX icon
89
Apyx Medical
APYX
$126M
$4.25M 0.22%
902,847
+77,730
+9% +$385K
FOLD
90
PUT
DELISTED
Amicus Therapeutics
FOLD
$4.24M 0.22%
+300,000
New +$4.37M
HOLX
91
CALL
DELISTED
Hologic
HOLX
$4.15M 0.21%
+62,500
New +$3.96M
ICUI icon
92
CALL
ICU Medical
ICUI
$4.48B
$4.11M 0.21%
22,500
-7,500
-25% -$1.41M
ZBH icon
93
CALL
Zimmer Biomet
ZBH
$18.7B
$4.08M 0.21%
+30,900
New +$4.04M
EXAS
94
CALL
DELISTED
Exact Sciences
EXAS
$4.08M 0.21%
+40,000
New +$3.45M
CMPS
95
Compass Pathways
CMPS
$1.97B
$4.03M 0.21%
+115,494
New +$4.15M
AVDL
96
DELISTED
Avadel Pharmaceuticals
AVDL
$4.01M 0.21%
795,200
+232,400
+41% +$1.69M
EW icon
97
PUT
Edwards Lifesciences
EW
$53.6B
$3.99M 0.21%
50,000
-17,000
-25% -$1.33M
ITMR
98
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.88M 0.2%
190,074
+12,527
+7% +$281K
ITCI
99
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.85M 0.2%
+150,000
New +$3.42M
OSUR icon
100
CALL
OraSure Technologies
OSUR
$259M
$3.77M 0.19%
+310,200
New +$4.24M

Similar funds

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.